POLARIS in the News
January 13th 2017
CHORUS was presented as a test case at the Conference on Research Ethics. ~150 IRB members from around the country weighed in on data sharing. The general consensus was that the court system could decide if identification was appropriate for criminal and identity cases.
October 15th 2016
Dr Alexander Lezhava will take on a new responsibility at GIS as the Program Director for POLARIS.
"With Prof Patrick Tan's move to BMRC as Deputy Executive Director, it is now a fitting transition for others at GIS to take the reins and move POLARIS to new heights in RIE2020. Sandro is a natural choice for this – coming from a strong hybrid academic/industry background, Sandro has during his past 3 years at GIS contributed significantly to the mission of GIS, including establishment of the ISO-certified Translational Research laboratory, initiation of 9 projects from industry and academic partners, which has brought in a collected revenue of >$3 million. Sandro was also instrumental in establishing the GIS-Pyrobett Joint Lab, which provides further inroads for GIS to deepen its engagement with industry."
September 30th 2016
POLARIS@GIS has passed the latest College of American Pathologist(CAP) inspection.
June 3rd 2015
POLARIS' efforts highlighted in Science Translational Medicine
"Singapore’s Personalized Omic Lattice for Advanced Research and Improving Stratification (POLARIS) project takes advantage of local expertise and interest in genomics and ophthalmology in launching a pilot effort of transforming growth factor–β-induced (TGFBI) sequencing to assess genetic risk for stromal corneal dystrophies. This effort will be followed by the implementation of a 90-gene panel that targets gastrointestinal cancers — diseases of high burden in Singapore —in a systematic effort to develop a nationwide framework for genetic and genomic testing."
Read the full article here
February 12th 2015
A study utilizing POLARIS technology was published in Genome Biology by Dr Iain Tan, NCCS Consultant and GIS Clinician-Scientist. Using the POLARIS Xplora™ Cancer panel designed to profile the top 800 most recurrently mutated genes in cancer, Dr Tan examined patterns of genetic mutations in colorectal cancer between primary tumors (those arising in the colon) from tumors that had spread to the liver.
The POLARIS Xplora™ Cancer panel is now available on a research-use basis – interested parties are encourage to contact email@example.com for more information.
Read the full article here
Collaborative study with Singapore's Ministry of Health (MOH) published in Emerging Infectious Diseases. In it, Mycobacterium Tuberculosis was used as a model to assess the role of NGS as a possible replacement for conventional genotyping methods for pathogen outbreak monitoring and disease epidemiology.